Login
← Go Back
Concord Biotech
CONCORDBIO · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 18, 2023
Stock Price vs Company Growth
1d
2.4%
1w
1.0%
1m
19.3%
3m
21.7%
6m
0.6%
1y
34.8%
all
13.7%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,341 2.4%
987
1,408
Company Overview
Sales
1,055 Cr
Growth: 4.0%
Profit after Tax
261 Cr
Growth: -16.5%
Mid Cap
14,025 Cr
P/E: 54.1x
Industry P/E: 31.3x
Fundamentals
Sales (Cr) ₹ 1,055
Growth 4.0%
EBITDA 34.8%
P/S 13.3x
Dividend 0.6%
P/E 54.1x
Book Value ₹ 193
PEG Ratio 13.8x
ROE 13.4%
P/B 7.1x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.
Belongs to (23 Indices) view more
Followers (1)
varsha96